title: Duchenne muscular dystrophy: current cell therapies.
abstract: Duchenne muscular dystrophy is a genetically determined X-linked disease and the most common, progressive pediatric muscle disorder. For decades, research has been conducted to find an effective therapy. This review presents current therapeutic methods for Duchenne muscular dystrophy, based on scientific articles in English published mainly in the period 2000 to 2014. We used the PubMed database to identify and review the most important studies. An analysis of contemporary studies of stem cell therapy and the use of granulocyte colony-stimulating factor (G-CSF) in muscular dystrophy was performed.
authors.affiliation: Department of Pediatric Rehabilitation Medical University, Bialystok, Poland.
authors.forename: Dorota
authors.initials: D
authors.lastname: Sienkiewicz
authors.affiliation: Department of Pediatric Rehabilitation, Medical University of Białystok, 15-274 Bialystok, 17 Waszyngtona street, Poland.
authors.forename: Wojciech
authors.initials: W
authors.lastname: Kulak
authors.affiliation: Department of Pediatric Rehabilitation Medical University, Bialystok, Poland.
authors.forename: Bożena
authors.initials: B
authors.lastname: Okurowska-Zawada
authors.affiliation: Department of Pediatric Rehabilitation Medical University, Bialystok, Poland.
authors.forename: Grażyna
authors.initials: G
authors.lastname: Paszko-Patej
authors.affiliation: Department of Pediatric Rehabilitation Medical University, Bialystok, Poland.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Kawnik
keywords: Duchenne muscular dystrophy; G-CSF; stem cells